Epipen 2-Pak (Epinephrine) Auto-Injectors shortage — US supply status & alternatives

Epipen 2-Pak (Epinephrine) Auto-Injectors

—

In supply · Australia

EpiPen 2-Pak Auto-Injectors

In supply · 🇦🇺 Australia · short in🇺🇸 US🇨🇦 CA🇮🇪 IE

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Brand names	EpiPen 2-Pak Auto-Injectors

Therapeutic category	Auto-created by FDA MedWatch — Drug Safety Alerts scraper

Controlled substance	No

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 12h ago

Critical

🇨🇦

Canada

Medsafe NZ Full · 3mo ago

High

🇮🇪

Ireland

HPRA · 17h ago

Medium

Recalls official enforcement reports

🇨🇦

EpiPen and EpiPen Jr auto

Communications and Public Affairs Branch · Sept 2018

Class ?details ↗

🇨🇦

EpiPen and EpiPen Jr Auto

Marketed health products · Dec 2011

Class ?details ↗

🇨🇦

EpiPen and EpiPen Jr Auto

Marketed health products · Dec 2011

Class ?details ↗

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.